MungerKLChitnisTAscherioA.Body size and risk of MS in two cohorts of US women. Neurology2009; 73(19): 1543–1550.
2.
HuppkeBEllenbergerDHummelH, et al. Association of obesity with multiple sclerosis risk and response to first-line disease modifying drugs in children. JAMA Neurol. Epub ahead of print 15July2019. DOI: 10.1001/jamaneurol.2019.
3.
TetteyPSimpsonSJrTaylorB, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler2014; 20(13): 1737–1744.
4.
TetteyPSimpsonSTaylorB, et al. An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event. J Neurol Neurosurg Psychiatry2017; 88(5): 395–401.
5.
Stampanoni BassiMIezziEButtariF, et al. Obesity worsens central inflammation and disability in multiple sclerosis. Mult Scler2020; 26(10): 1237–1246.
6.
MatareseGCarrieriPBMontellaS, et al. Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol2010; 6(8): 455–461.
7.
HaghikiaAJörgSDuschaA, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity2016; 44(4): 951–953.
ChoiIYPiccioLChildressP, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep2016; 15(10): 2136–2146.
10.
EvansELevasseurVCrossAH, et al. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord2019; 36: 101393.
